These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31401307)

  • 1. IL18 gene polymorphism and its influence on CD4+ T-cell recovery in HIV-positive patients receiving antiretroviral therapy.
    Andrade-Santos JL; Carvalho-Silva WHV; Coelho AVC; Souto FO; Crovella S; Brandão LAC; Guimarães RL
    Infect Genet Evol; 2019 Nov; 75():103997. PubMed ID: 31401307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
    Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
    J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
    Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
    Gene; 2020 May; 741():144568. PubMed ID: 32165289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.
    Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Micheloud D; García-Álvarez M; Bellón JM; Aldámiz-Echevarría T; García-Broncano P; Catalán P; Diez C; Pineda-Tenor D; Resino S
    Eur J Clin Invest; 2015 Nov; 45(11):1192-9. PubMed ID: 26402121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic Exhaustion and Increased Immune Activation Are the Main Mechanisms Involved in Impaired Immunological Recovery of HIV-Positive Patients under ART.
    Dos Santos Guedes MC; Carvalho-Silva WHV; Andrade-Santos JL; Brelaz-de-Castro MCA; Souto FO; Guimarães RL
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
    Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
    Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
    Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of recent thymic emigrant CD4
    Barboni G; Balbaryski J; Urioste A; Candi M; Laucella S; Gaddi E
    Scand J Immunol; 2020 Mar; 91(3):e12838. PubMed ID: 31630413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in pyroptosis of recent thymic emigrants CD4+ T Lymphocytes in ART-treated HIV-positive patients are influenced by sex.
    Andrade-Santos JL; Carvalho-Silva WHV; Souto FO; Crovella S; Guimarães RL
    Immunogenetics; 2021 Aug; 73(4):349-353. PubMed ID: 33449124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Polymorphisms in TNF-α/TNFR1 Pathway Genes Are Associated With CD4+ T-Cell Recovery in HIV-1-Infected Individuals on Antiretroviral Therapy.
    Celerino da Silva R; Alves NMP; Gondim Silva ML; Agrelli A; Coelho AVC; Guimarães RL; Arraes LC; Crovella S; Brandão LAC
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):322-327. PubMed ID: 34267056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism rs1385129 Within Glut1 Gene
    Masson JJR; Cherry CL; Murphy NM; Sada-Ovalle I; Hussain T; Palchaudhuri R; Martinson J; Landay AL; Billah B; Crowe SM; Palmer CS
    Front Immunol; 2018; 9():900. PubMed ID: 29867928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy.
    Rb-Silva R; Nobrega C; Azevedo C; Athayde E; Canto-Gomes J; Ferreira I; Cheynier R; Yates AJ; Horta A; Correia-Neves M
    Front Immunol; 2019; 10():25. PubMed ID: 30804925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.
    Zhang LX; Song JW; Zhang C; Fan X; Huang HH; Xu RN; Liu JY; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS; Jiao YM
    Clin Immunol; 2021 Aug; 229():108773. PubMed ID: 34102315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 28B rs12979860 genotype and Human Immunodeficiency Virus type 1: Susceptibility, AIDS development and therapeutic outcome.
    Zaidane I; Wakrim L; Oulad Lahsen A; Bensghir R; Chihab H; Jadid FZ; El Fihry R; Lamdini H; Fayssel N; Marhoum El Filali K; Oudghiri M; Benjelloun S; Ezzikouri S
    Hum Immunol; 2018 Jan; 79(1):70-75. PubMed ID: 29080719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
    Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
    Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
    Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
    Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.
    Vos WAJW; Navas A; Meeder EMG; Blaauw MJT; Groenendijk AL; van Eekeren LE; Otten T; Vadaq N; Matzaraki V; van Cranenbroek B; Brinkman K; van Lunzen J; Joosten LAB; Netea MG; Blok WL; van der Ven AJAM; Koenen HJPM; Stalenhoef JE
    Front Immunol; 2024; 15():1350065. PubMed ID: 38779686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.